The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth
Abstract
Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and insulin are believed to be important in the regulation of fetal and neonatal growth. We previously reported that the profiles of IGFBPs in fetal cord serum (FCS) were dependent on the growth/metabolic status of the fetus. The goals of the current study were to examine the IGF system in FCS from term fetuses with normal growth, those with intrauterine growth retardation (IUGR), and those who were large for gestational age (LGA) and in FCS from normal weight preterm (25-37 weeks) and term fetuses in the neonatal period from the day of birth (day 0) until 7 days of age (day 7). Western ligand blotting (WLB) of term FCS revealed IGFBPs with mol wt of 43 and 38 kilodaltons (kDa; IGFBP-3), 34 kDa (IGFBP-2), 28 kDa (IGFBP-1 and glycosylated IGFBP-4), and 24 kDa (IGFBP-4). In IUGR FCS, there was a 50% decrease in IGFBP-3 detected by WLB, which was shown not to be due to an IGFBP-3 protease in IUGR sera. In LGA FCS, IGFBP-3 levels were elevated 2-fold by densitometric analysis of ligand blots. In normal term FCS, the following levels (+/- SE) were present: IGF-I, 76 +/- 16; IGF-II, 401 +/- 38; IGFBP-3, 700 +/- 112; IGFBP-1, 77 +/- 10 ng/mL; and insulin, 3.8 +/- 1.6 microU/mL. In IUGR FCS, IGF-I, IGF-II, and IGFBP-3 were significantly reduced, and IGFBP-1 was 7-fold higher than in FCS from normal weight fetuses. In LGA FCS, IGF-I, insulin, and IGFBP-3 were significantly increased, whereas IGFBP-1 was significantly decreased. During the neonatal period, IGF-I levels on day 0 were 4-fold higher in FCS from term (38-40 weeks) compared to preterm (25-31 weeks) newborns. FCS IGF-II levels did not change significantly on day 0 between 25-40 weeks gestation. In the first 7 days of postnatal life, IGF-I levels were unchanged in preterm newborns, whereas in term neonates, IGF-I levels decreased precipitously on day 1, remained low during the first 3 days of life, and returned to birth levels by the end of the first week. In contrast, IGF-II and IGFBP-3 levels did not significantly change during the first week of life in preterm or term newborns.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical assessment of gestational age in the newborn infant
Dubowitz, L. M. S., Dubowitz, V., & Goldberg, C. (1970) · The Journal of Pediatrics · doi:10.1016/s0022-3476(70)80038-5 · Cited by 2,241
Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., & Binoux, M. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90507-5 · Cited by 1,143
Lubchenco, L. O., Hansman, C., & Boyd, E. (1966) · Pediatrics · doi:10.1542/peds.37.3.403 · Cited by 1,079
Lassarre, C., Hardouin, S., Daffos, F., Forestier, F., Frankenne, F., & Binoux, M. (1991) · Pediatric Research · doi:10.1203/00006450-199103000-00001 · Cited by 411
GIUDICE, L. C., FARRELL, E. M., PHAM, H., LAMSON, G., & ROSENFELD, R. G. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-806 · Cited by 361
Self-citationBar, R. S., Boes, M., Clemmons, D. R., Busby, W. H., Sandra, A., Dake, B. L., & Booth, B. A. (1990) · Endocrinology · doi:10.1210/endo-127-1-497 · Cited by 175
GLASS, P., ROSENFELD, R. G., BAKER, B. K., LIU, F., & HINTZ, R. L. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-5-1186 · Cited by 167
Ooi, G. T., Orlowski, C. C., Brown, A. L., Becker, R. E., Unterman, T. G., & Rechler, M. M. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-2-321 · Cited by 164
Unterman, T. G., Simmons, R. A., Glick, R. P., & Ogata, E. S. (1993) · Endocrinology · doi:10.1210/en.132.1.327 · Cited by 113
Unterman, T. G., Lascon, R., Gotway, M. B., OEHLER, D. T., Gounis, A. S., Simmons, R. A., & Ogata, E. S. (1990) · Endocrinology · doi:10.1210/endo-127-4-2035 · Cited by 97
Orlowski, C. C., Brown, A. L., Ooi, G. T., Yang, Y. W.-H., Tseng, L. Y.-H., & Rechler, M. M. (1990) · Endocrinology · doi:10.1210/endo-126-1-644 · Cited by 96
McLellan, K. C., Hooper, S. B., Bocking, A. D., et al. (1992) · Endocrinology · doi:10.1210/endo.131.4.1382958 · Cited by 83
Hormonal control of growth in the human fetus
Chard, T. (1989) · Journal of Endocrinology · doi:10.1677/joe.0.1230003 · Cited by 53
Pannier, E., Irwin, J. C., & Giudice, L. C. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90092-2 · Cited by 25
Self-citation
Cited by
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
Woods, K. A., Camacho-Hübner, C., Savage, M. O., & Clark, A. J. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351805 · Cited by 1,085
Rosen, C. L., Larkin, E. K., Kirchner, H. L., Emancipator, J. L., Bivins, S. F., Surovec, S. A., Martin, R. J., & Redline, S. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.28 · Cited by 743
Malaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628
Chen, J., & Smith, L. E. H. (2007) · Angiogenesis · doi:10.1007/s10456-007-9066-0 · Cited by 602
Metadata
- Authors
- Giudice, L. C.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1995-05-01
- Volume
- 80
- Issue
- 5
- Pages
- 1548-1555
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1986734640
- Cited by
- 383
- References
- 14
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.